TREA

98181812 - BYSANTI

Follow

Information

  • Trademark
  • 98181812
  • Serial Number
    98181812
  • Filing Date
    September 15, 2023
    a year ago
  • Transaction Date
    March 03, 2025
    a month ago
  • Status Date
    January 02, 2025
    3 months ago
  • Published for Opposition Date
    June 11, 2024
    9 months ago
  • Location Date
    August 06, 2024
    8 months ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    LOZEAU, BRANDON
  • Attorney Docket Number
    VAND-0268
    Attorney Name
    Jayme M. Torelli
    Law Office Assigned Location Code
    N90
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BYSANTI
Case File Statements
  • GS0051: Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of insomnia; Pharmaceutical preparations for the treatment and prevention of social anxiety; Pharmaceutical preparations for the treatment and prevention of performance anxiety; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of Parkinson's Disease psychosis; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of Delayed Sleep Phase Disorder (DSPD); Pharmaceutical preparations for the treatment of Autism Spectrum Disorder (ASD); Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of covid-19 pneumonia; Pharmaceutical preparations for the treatment of hematologic malignancies; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology
Case File Event Statements
  • 9/15/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/9/2024 - 11 months ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/30/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/9/2024 - 11 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/11/2024 - 9 months ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/11/2024 - 9 months ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/6/2024 - 8 months ago
    8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/2/2025 - 3 months ago
    9 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/22/2024 - 10 months ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/2/2025 - 3 months ago
    10 - SOU EXTENSION 1 FILED Type: EXT1
  • 1/3/2025 - 3 months ago
    11 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 3/4/2025 - a month ago
    12 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA